APA (7th ed.) Citation

Ronellenfitsch, U., Karampinis, I., Jakob, J., Kasper, B., Nowak, K., Pilz, L. R., . . . Hohenberger, P. (2019). Preoperative pazopanib in high-risk soft tissue sarcoma: Phase II window-of opportunity study of the german interdisciplinary sarcoma group (NOPASS/GISG-04). Annals of surgical oncology, 26(5), . https://doi.org/10.1245/s10434-019-07183-4

Chicago Style (17th ed.) Citation

Ronellenfitsch, Ulrich, Ioannis Karampinis, Jens Jakob, Bernd Kasper, Kai Nowak, Lothar R. Pilz, Ulrike Attenberger, Timo Gaiser, and Peter Hohenberger. "Preoperative Pazopanib in High-risk Soft Tissue Sarcoma: Phase II Window-of Opportunity Study of the German Interdisciplinary Sarcoma Group (NOPASS/GISG-04)." Annals of Surgical Oncology 26, no. 5 (2019). https://doi.org/10.1245/s10434-019-07183-4.

MLA (9th ed.) Citation

Ronellenfitsch, Ulrich, et al. "Preoperative Pazopanib in High-risk Soft Tissue Sarcoma: Phase II Window-of Opportunity Study of the German Interdisciplinary Sarcoma Group (NOPASS/GISG-04)." Annals of Surgical Oncology, vol. 26, no. 5, 2019, https://doi.org/10.1245/s10434-019-07183-4.